Detalhe da pesquisa
1.
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis.
Hum Mol Genet
; 31(13): 2155-2163, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088080
2.
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry.
J Neurol Neurosurg Psychiatry
; 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242680
3.
No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry.
Mult Scler
; : 13524585241240406, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38511853
4.
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.
Brain
; 146(6): 2316-2331, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36448302
5.
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain
; 146(11): 4633-4644, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369086
6.
Risk of secondary progressive multiple sclerosis after early worsening of disability.
J Neurol Neurosurg Psychiatry
; 94(12): 984-991, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414538
7.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068931
8.
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult Scler
; 29(3): 326-332, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800908
9.
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur J Neurol
; 30(4): 1014-1024, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692895
10.
Forest disturbances and climate constrain carbon allocation dynamics in trees.
Glob Chang Biol
; 28(14): 4342-4358, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35322511
11.
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry.
J Neurol Neurosurg Psychiatry
; 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180218
12.
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 93(12): 1330-1337, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261289
13.
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.
Mult Scler
; 28(6): 910-924, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605319
14.
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Mult Scler
; 28(11): 1752-1761, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373638
15.
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
Eur J Neurol
; 29(4): 1082-1090, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724638
16.
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur J Neurol
; 29(8): 2321-2334, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582938
17.
The role of maternal age, growth, and environment in shaping offspring performance in an aerial conifer seed bank.
Am J Bot
; 109(3): 366-376, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973037
18.
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.
PLoS Genet
; 15(6): e1008180, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31170158
19.
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.
Nat Immunol
; 10(9): 958-64, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19684606
20.
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score.
Mult Scler
; 27(5): 695-705, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32639855